Crizotinib and Ganetespib (STA-9090) in ALK Positive Lung Cancers
Clinical trial NCT01579994 · COMPLETED
Trial details
- NCT number
- NCT01579994
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-16
- Primary completion
- 2020-12-28
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.